Headline: Adial Pharmaceuticals (ADIL) Executes 1-for-25 Reverse Stock Split
Date: 2026-02-04 14:00 PT
Source: SEC Edgar (8-K)
Category: Capital Structure / Reverse Split
Adial Pharmaceuticals filed an amendment to effect a 1-for-25 reverse stock split (Item 5.03). The split will become effective at 11:59 p.m. ET on February 5, 2026, with trading on a split-adjusted basis commencing the following day. The action maintains the authorized share count.
